Ignite Creation Date:
2024-05-05 @ 6:35 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00518687
Status:
TERMINATED
Last Update Posted:
2015-10-02
First Post:
2007-08-17
Brief Title:
Efficacy Immunogenicity and Safety of a Single Dose of V710 in Adult Patients Scheduled for Cardiothoracic Surgery V710-003 AM2
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Study Overview
Official Title:
A Randomized Multicenter Double-Blind Group-Sequential Study to Evaluate the Efficacy Immunogenicity and Safety of a Single Dose of Merck 0657nI Staphylococcus Aureus Vaccine V710 in Adult Patients Scheduled for Cardiothoracic Surgery
Status:
TERMINATED
Status Verified Date:
2015-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will assess the efficacy of a single dose of V710 vaccine to prevent serious Staphylococcus aureus infections following elective cardiothoracic surgery The study will also evaluate the immune response and general safety of the V710 vaccine
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2007_523 | OTHER | Merck | None |